EA200300002A1 - Способ синтеза (2r,2-альфа-r,3а)-2-[1-(3,5-бис(трифторметил)фенил)этокси]-3-(4-фторфенил)-1,4-оксазина - Google Patents

Способ синтеза (2r,2-альфа-r,3а)-2-[1-(3,5-бис(трифторметил)фенил)этокси]-3-(4-фторфенил)-1,4-оксазина

Info

Publication number
EA200300002A1
EA200300002A1 EA200300002A EA200300002A EA200300002A1 EA 200300002 A1 EA200300002 A1 EA 200300002A1 EA 200300002 A EA200300002 A EA 200300002A EA 200300002 A EA200300002 A EA 200300002A EA 200300002 A1 EA200300002 A1 EA 200300002A1
Authority
EA
Eurasian Patent Office
Prior art keywords
oxazine
alpha
bis
phenyl
synthesis
Prior art date
Application number
EA200300002A
Other languages
English (en)
Other versions
EA004743B1 (ru
Inventor
Карел М. Ес Брэндс
Фух-Ронг Цай
Карен М. Конрад
Мэттью М. Зао
Original Assignee
Мерк Энд Ко., Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Энд Ко., Инк. filed Critical Мерк Энд Ко., Инк.
Publication of EA200300002A1 publication Critical patent/EA200300002A1/ru
Publication of EA004743B1 publication Critical patent/EA004743B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Настоящее изобретение касается способа получения (2R,2-альфа-R,3а)-2-[1-[3,5-бис(трифторметил)фенил]этокси-3-(4-фторфенил)-1,4-оксазина. Указанное соединение полезно в качестве промежуточного продукта при синтезе соединений, обладающих фармакологической активностью.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200300002A 2000-06-08 2001-06-04 Способ синтеза (2r,2-альфа-r,3a)-2-[1-[3,5-бис(трифторметил)фенил]этокси]-3-(4-фторфенил)-1,4-оксазина EA004743B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21020300P 2000-06-08 2000-06-08
PCT/US2001/018042 WO2001094324A1 (en) 2000-06-08 2001-06-04 Process for the synthesis of (2r, 2-alpha-r, 3a)-2-[1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine

Publications (2)

Publication Number Publication Date
EA200300002A1 true EA200300002A1 (ru) 2003-04-24
EA004743B1 EA004743B1 (ru) 2004-08-26

Family

ID=22781976

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300002A EA004743B1 (ru) 2000-06-08 2001-06-04 Способ синтеза (2r,2-альфа-r,3a)-2-[1-[3,5-бис(трифторметил)фенил]этокси]-3-(4-фторфенил)-1,4-оксазина

Country Status (19)

Country Link
US (1) US6600040B2 (ru)
EP (1) EP1292584A1 (ru)
JP (1) JP2003535852A (ru)
KR (1) KR20030007887A (ru)
CN (1) CN1182125C (ru)
AR (1) AR030284A1 (ru)
AU (1) AU2001268170A1 (ru)
BR (1) BR0111472A (ru)
CA (1) CA2410404A1 (ru)
CZ (1) CZ20024013A3 (ru)
EA (1) EA004743B1 (ru)
HR (1) HRP20020973A2 (ru)
HU (1) HUP0400491A2 (ru)
IL (1) IL152793A0 (ru)
MX (1) MXPA02012101A (ru)
NZ (1) NZ523389A (ru)
PL (1) PL359137A1 (ru)
SK (1) SK17082002A3 (ru)
WO (1) WO2001094324A1 (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001266690A1 (en) * 2000-06-08 2001-12-17 Merck And Co., Inc. Process for the synthesis of (2r, 2-alpha-r)-4-benzyl-2-(1-(3,5-bis(trifluoromethyl)phenyl) ethoxy)-1,4-oxazin-3-one
FR2876101B1 (fr) 2004-10-05 2007-03-02 Sidem Pharma Sa Sa Procede de preparation enantioselective de derives de sulfoxydes
WO2012146692A1 (en) 2011-04-29 2012-11-01 Sandoz Ag Novel intermediates for the preparation of highly pure aprepitant or fosaprepitant
CN103012305B (zh) * 2011-09-23 2016-08-17 江苏豪森药业集团有限公司 一种福沙匹坦中间体的制备方法
CN103030668B (zh) * 2011-10-09 2016-06-15 江苏豪森药业集团有限公司 一种制备福沙匹坦二甲葡胺的方法
CZ304770B6 (cs) 2012-03-13 2014-10-08 Zentiva, K.S. Způsob výroby 3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluormethyl)fenyl)ethoxy)-3-(4-fluorfenyl)morfolino)methyl)-1H-1,2,4-triazol-5(4H)-onu (Aprepitantu) v polymorfní formě II
CN102675240B (zh) * 2012-04-13 2015-01-14 浙江海正药业股份有限公司 4-取代基-2-羟基吗啉-3-酮及其制备方法
CN104327009B (zh) * 2014-09-24 2016-07-20 山东省生物医药科学院 一种阿瑞匹坦关键中间体的精制方法
CN104447607B (zh) * 2014-12-12 2017-02-22 瑞阳制药有限公司 阿瑞匹坦中间体的制备方法
CN104557760A (zh) * 2015-01-28 2015-04-29 武汉励合生物医药科技有限公司 阿瑞吡坦中间体的制备方法
CN106397349A (zh) * 2016-08-31 2017-02-15 安徽省润生医药股份有限公司 一种阿瑞吡坦中间体及其制备方法
CN109516964B (zh) * 2017-09-19 2022-05-31 鲁南制药集团股份有限公司 一种阿瑞匹坦中间体的制备方法
CN109694360A (zh) * 2018-12-28 2019-04-30 凯瑞斯德生化(苏州)有限公司 一种阿瑞匹坦中间体的制备方法
CN110746371B (zh) * 2019-11-20 2022-07-15 山东鲁抗医药股份有限公司 制备阿瑞匹坦的中间体及其制备方法与应用
CN111665016B (zh) * 2020-06-09 2022-03-08 重庆交通大学 一种河道泡漩结构识别跟踪方法及通航预警方法
CN111829749A (zh) * 2020-07-27 2020-10-27 中国空气动力研究与发展中心高速空气动力研究所 一种用于风洞超声速流校大行程单点移测装置及布线方法
CN113582982B (zh) * 2021-06-15 2023-06-16 山东罗欣药业集团股份有限公司 一种nk1受体拮抗剂的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
IL111960A (en) * 1993-12-17 1999-12-22 Merck & Co Inc Morpholines and thiomorpholines their preparation and pharmaceutical compositions containing them
SG52217A1 (en) 1993-12-29 1998-09-28 Merck Sharp & Dohme Substituted morpholine derivatives and their use as therapeutic agents
ZA985765B (en) 1997-07-02 1999-08-04 Merck & Co Inc Polymorphic form of a tachykinin receptor antagonist.
GB9813025D0 (en) 1998-06-16 1998-08-12 Merck Sharp & Dohme Chemical synthesis
EP1112259A4 (en) * 1998-09-11 2002-01-09 Merck & Co Inc METHOD FOR SYNTHESISING N-BENZYL-3- (4-FLUOROPHENYL) -1,4-OXAZIN-2-ON
CA2348526A1 (en) 1998-10-30 2000-05-11 Merck & Co., Inc. Process for the preparation of 2-(r)-(1- (r)-(3,5-bis (trifluoromethyl) phenyl)ethoxy) -4-((5-dimethylaminomethyl) -1,2,3-triazol -4-yl)methyl) -3-(s)-(4- fluorophenyl) morpholine
AU1230000A (en) * 1998-10-30 2000-05-22 Merck & Co., Inc. Linear process for the preparation of a morpholine compound
BR9916615A (pt) * 1998-12-29 2001-10-23 Upjohn Co Método para a preparação de éteres de arila

Also Published As

Publication number Publication date
US6600040B2 (en) 2003-07-29
EA004743B1 (ru) 2004-08-26
HUP0400491A2 (hu) 2004-06-28
SK17082002A3 (sk) 2003-04-01
CN1436178A (zh) 2003-08-13
EP1292584A1 (en) 2003-03-19
AU2001268170A1 (en) 2001-12-17
KR20030007887A (ko) 2003-01-23
CZ20024013A3 (cs) 2003-03-12
US20020052494A1 (en) 2002-05-02
HRP20020973A2 (en) 2005-02-28
CA2410404A1 (en) 2001-12-13
CN1182125C (zh) 2004-12-29
IL152793A0 (en) 2003-06-24
JP2003535852A (ja) 2003-12-02
BR0111472A (pt) 2004-01-06
AR030284A1 (es) 2003-08-20
MXPA02012101A (es) 2003-04-25
PL359137A1 (en) 2004-08-23
NZ523389A (en) 2004-08-27
WO2001094324A1 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
EA200300002A1 (ru) Способ синтеза (2r,2-альфа-r,3а)-2-[1-(3,5-бис(трифторметил)фенил)этокси]-3-(4-фторфенил)-1,4-оксазина
ATE432007T1 (de) Fungizide ternäre wirkstoffkombinationen
NO20020214L (no) Substituerte oksoazaheterocyklylforbindelser
EA200101081A1 (ru) Способ получения циталопрама
ES545885A0 (es) Un metodo para preparar 4-(4-(dimetilamino)-1-(4'-fluoro- fenil)-1-hidroxibutil)-3-(hidroximetil)-benzonitrilo
EA200600925A1 (ru) Производные триазола в качестве антагонистов вазопрессина
EA199800051A1 (ru) Производные бензамида и их применение в качестве антагонистов вазопрессина
DE69931393D1 (de) Antithrombotische amide
ATE394373T1 (de) Synthese von indolthiazolverbindungen als liganden des ah-rezeptors
PE20050682A1 (es) 1-(4-mono- y di-halometilsulfonilfenil)-2-acilamino-3-fluorpropanoles antibacterianos y su preparacion
EA200400748A1 (ru) Агонисты рецепторов, активируемых пероксисомным пролифератором
EA200200819A1 (ru) Кристаллическая форма ii линезолида
EA200400487A1 (ru) Фармацевтическая композиция длительного высвобождения, содержащая метформин
BR0212763B1 (pt) difosfinas e sua utilizaÇço em sÍntese assimÉtrica.
EA199901098A1 (ru) Новый способ
EA200100040A1 (ru) Химический синтез морфолиновых производных
EA200200101A1 (ru) Получение замещенных пиперидин-4-онов
EA200400588A1 (ru) Линейные основные соединения, имеющие антагонистическую активность в отношении nk-2, и их композиции
AR031366A1 (es) Proceso para la sintesis de (r) -1 -(3,5-bis (trifluormetil)- fenil) etan-1-ol mediante hidrogenacion detransferencia asimetrica
BR9707356A (pt) Composto processo para preparação do mesmo composição fingicida e processo para combater fungos
AU2001269749A1 (en) Trans-glycosidation process for the synthesis of (2r, 2-alpha-r, 3a)-2-(1-(3,5-bis(trifluoromethyl)phenyl) ethoxy)-3-(4-fluorophenyl)-1,4-oxazine
EA200000127A1 (ru) Способ получения аминопроизводных алкилоксифуранона, получаемые этим способом соединения и применение этих соединений
ATE258182T1 (de) Verbindungen selektif-inhibitoren der t gamma 9 delta 2 lymphocyten
EA199900770A1 (ru) Способ получения фармацевтических соединений
RU2342363C2 (ru) Бензоилпиперидиновые соединения

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM